A partnership between TU Delft, DSM, VIVOLTA, and Meatable has been awarded an Open
Technology Program grant by the NWO (Dutch Research Council) for research into the use
of protein-based biopolymers for potential food and healthcare applications, including soft
tissue repair. The grant of one million euros will fund a five-year research project into the
scalability and cost-effectiveness of producing elastin-like polypeptides (ELPs) and non-
animal derived collagen. The project will be led by prof. dr. Gijsje Koenderink, professor at
the Bio nanoscience Department, and prof. dr. Jean-Marc Daran, who specializes in
Industrial Microbiology at TU Delft.
DSM’s world-class biotechnology competences will be critical in producing synthetic
biopolymer prototypes to be studied by the other consortium members. DSM Biomedical,
part of DSM and the world’s biomaterials expert, will leverage their longstanding expertise
to assess the non-animal derived prototypes and post-process scaffolds for soft tissue repair
applications. VIVOLTA will assess the recombinant materials for electrospinning feasibility in
pure and composite materials.
Meatable will test the prototypes as scaffolds and conduct a digestibility study on the
optimized ELPs, which can contribute towards scaling the production of cultivated meats
and whole cuts. Meatable works with porcine and bovine
pluripotent stem cells (PSCs) in (perfusion) bioreactors using opti-ox technology; a process
in which ELPs have the potential to offer better cell differentiation and tissue development.
These benefits could improve the meat quality and process efficiency, bringing Meatable
closer to realizing its mission: delicious meat without the drawbacks on animal welfare.
Tue 23 May 2023
Meatable has reached a major milestone in the company’s history: our technology can now create cultivated pork products in eight days, thanks to its unique and superior differentiation process.
Thu 11 May 2023
Meatable held its first-ever cultivated meat tasting in Singapore with future commercial partners and the Singapore Economic Development Board. The company received approval from the Singapore Food Agency for this first tasting, an important step towards receiving regulatory approval for sale of its cultivated meat. With this milestone, Meatable is on track to launch into the Singaporean market in 2024, followed by the US.
Mon 09 Jan 2023
For cultivated meat companies, 2022 will be remembered as a year in which we navigated the evolving environment of consumers and investors and a truly diverse global regulatory landscape. It's safe to say that last year saw some of the biggest developments to date in cultivated meat. But what’s next on the agenda? Here are my predictions for how the cultivated meat industry will change and develop in 2023.